Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 12, 2024Hematological OncologyOpen Access

Efficacy of escalating therapy with brentuximab vedotin‐AVD in advanced stage Hodgkin lymphoma patients with positive interim positron emission tomography after ABVD

View Full Paper
Ask AI
Bookmark
Share

Authors

CMCarmen Martı́nezECEsther CarceleroAGAntonio Gutiérrez

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Martı́nez et al. (2024) studied this question.

synapsesocial.com/papers/68e5c976b6db64358755fdf2https://doi.org/10.1002/hon.3299
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma2019 · 132 citations
  2. 2US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose–Positron Emission Tomography Imaging: Southwest Oncology Group S08162016 · 268 citations
  3. 3FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma2005 · 725 citations
  4. 4Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma2015 · 760 citations
  5. 5Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group2014 · 1,677 citations